Antonio Iavarone

University of Miami

Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

h-index75

i10-index136

Publications428

Citations28,299

Grants

45 total · 11 active

NIH #5UE5NS108937-07

University of MIami Neurosurgery eDucation Strategy UMINDS

Active

Amount: $0K
Period: 2019-09-01 → 2029-08-31
PIs: 3
Est. capacity / PI: ~0 students

Awarded at UNIVERSITY OF MIAMI SCHOOL OF MEDICINE

NIH #2R25NS108937-06

University of MIami Neurosurgery eDucation Strategy UMINDS

Active

Amount: $90K
Period: 2019-09-01 → 2029-08-31
PIs: 3
Est. capacity / PI: ~0 students

Awarded at UNIVERSITY OF MIAMI SCHOOL OF MEDICINE

NIH #5R35CA253183-06

Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors

Active

Amount: $921K
Period: 2021-09-24 → 2028-08-31
PIs: 1
Est. capacity / PI: ~4 students

Awarded at UNIVERSITY OF MIAMI SCHOOL OF MEDICINE

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0172

PageRank within Genetics co-authorship network

Explore collaboration map

Admission Signals

New paper: Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma (bioRxiv (Cold Spring Harbor Laboratory))2026-06-09
New NIH award: $402K — Evolution and targeting of the functional states of glioblastoma2022-07-01
New NIH award: $382K — Evolution and targeting of the functional states of glioblastoma2022-07-01
New NIH award: $394K — Evolution and targeting of the functional states of glioblastoma2022-07-01
New NIH award: $162K — Evolution and targeting of the functional states of glioblastoma2022-07-01
New NIH award: $921K — Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors2021-09-24
New NIH award: $875K — Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors2021-09-24
New NIH award: $825K — Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors2021-09-24
New NIH award: $827K — Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors2021-09-24
New NIH award: $663K — Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors2021-09-24

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0002-0683-4634

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 44

Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma
bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-09
Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression
Experimental & Molecular Medicine · 2026-06-05
Acquired genetic and cell-state changes in IDH-mutant glioma progression
Nature · 2026-06-03
Abstract 6133: Horizontal mitochondria transfer stimulates pro-tumorigenic astrocyte reprogramming in glioblastoma
Cancer Research · 2026-04-03
Abstract IA005: Shaping tumor cell plasticity and therapy resistance in glioblastoma
Cancer Research · 2026-03-23
Supplementary Figure S8 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Figure S1. from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Figure S6 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Figure S2 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Figure S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Figure S5 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Figure S7 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Figure S4 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
Supplementary Tables S1-S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
2025-12-11
157 A novel multi-omic algorithm to predict real-world outcomes among patients with rare, advanced, solid cancers treated with off-label immune checkpoint inhibitors
Regular and Young Investigator Award Abstracts · 2025-11-01
BIOM-47. DECIPHERING GLIOBLASTOMA HETEROGENEITY: INTEGRATING MOLECULAR SIGNATURES AND GENOMIC LANDSCAPES TO PREDICT DRUG SENSITIVITY AND ADVANCE PRECISION ONCOLOGY
Neuro-Oncology · 2025-11-01
CTNI-61. A PHASE 2 STUDY OF ERDAFITINIB IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH-WILD TYPE GLIOMA WITH FGFR-TACC GENE FUSIONS: SAFETY RUN-IN COHORT RESULTS
Neuro-Oncology · 2025-11-01 · 1 citations
BIOM-93. PROGNOSTIC AND PREDICTIVE IMPLICATIONS OF BRAF V600 MUTATIONS IN ADULT HIGH-GRADE GLIOMAS
Neuro-Oncology · 2025-11-01
EPCO-21. SINGLE-NUCLEI ANALYSIS IDENTIFIES NOVEL NEOPLASTIC IDH MUTANT ASTROCYTOMA PROLIFERATIVE AND STEMNESS PHENOTYPES DRIVING POOR PATIENT OUTCOMES
Neuro-Oncology · 2025-11-01
TMIC-36. Intercellular mitochondria transfer drives immunosuppressive astrocyte reprogramming in glioblastoma
Neuro-Oncology · 2025-11-01

Open author page on OpenAlex →